Blog
Relief Therapeutics Holding SA and NRx Pharmaceuticals, Inc. Announce Execution of Definitive Settlement Agreements
Relief Therapeutics Holding SA and NRx Pharmaceuticals, Inc. Announce Execution of Definitive Settlement Agreements
EQS-News: Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. to Report Q3 2022 Financial Results and Operational Progress on November 22, 2022
EQS-News: Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. to Report Q3 2022 Financial Results and Operational Progress on November 22, 2022
EQS-News: JDC Group AG: JDC grows 12 percent in first nine months of 2022 despite inflation-driven spending restraint
EQS-News: JDC Group AG: JDC grows 12 percent in first nine months of 2022 despite inflation-driven spending restraint
Achiko AG Commences Commercial Deliveries in Indonesia
Achiko AG Commences Commercial Deliveries in Indonesia
EQS-Adhoc: Vulcan Energy Resources Limited: Vulcan Energie Ressourcen GmbH has successfully developed and tested a proprietary lithium extraction sorbent for sustainable lithium extraction from the Upper Rhine G
EQS-Adhoc: Vulcan Energy Resources Limited: Vulcan Energie Ressourcen GmbH has successfully developed and tested a proprietary lithium extraction sorbent for sustainable lithium extraction from the Upper Rhine G
EQS-Adhoc: Rheinmetall AG: Rheinmetall takes over Spain’s Expal Systems S.A. / Move brings the Group new ammunition production capacity
EQS-Adhoc: Rheinmetall AG: Rheinmetall takes over Spain’s Expal Systems S.A. / Move brings the Group new ammunition production capacity
TaTaTu S.p.A.: PROPOSED CAPITAL INCREASE WITH EXCLUSION OF THE PRE-EMPTION RIGHT TO BE OFFERED TO ANIVAD CONSULTING LTD FOR AN AMOUNT EQUAL TO EURO 2,650,000
TaTaTu S.p.A.: PROPOSED CAPITAL INCREASE WITH EXCLUSION OF THE PRE-EMPTION RIGHT TO BE OFFERED TO ANIVAD CONSULTING LTD FOR AN AMOUNT EQUAL TO EURO 2,650,000
EQS-Adhoc: JDC Group AG: Adjustment of the forecast for the fiscal year 2022
EQS-Adhoc: JDC Group AG: Adjustment of the forecast for the fiscal year 2022
First Time Joining Taobao Double Eleven Festival, Macau Pass MPay's Online Payment Traffic Peaked by 20 Times
First Time Joining Taobao Double Eleven Festival, Macau Pass MPay's Online Payment Traffic Peaked by 20 Times
Turkiye Garanti Bankasi A.S.: Coupon Rate of Subordinated Debt Securities to Qualified Investors
Turkiye Garanti Bankasi A.S.: Coupon Rate of Subordinated Debt Securities to Qualified Investors
EQS-News: ADM Energy PLC: TR-1: Notification of major holdings
EQS-News: ADM Energy PLC: TR-1: Notification of major holdings
Fuller, Smith & Turner PLC: Transaction in Own Shares
Fuller, Smith & Turner PLC: Transaction in Own Shares
Edisun Power Europe AG: New solar plant of 23 MW starts solar power production
Edisun Power Europe AG: New solar plant of 23 MW starts solar power production
VK Company: Director/Person Discharging Managerial Responsibilities (“PDMR”)/Person Closely Associated (“PCA”) Shareholding
VK Company: Director/Person Discharging Managerial Responsibilities (“PDMR”)/Person Closely Associated (“PCA”) Shareholding
Partners Group acquires EdgeCore Digital Infrastructure, a hyperscale data center platform in the US
Partners Group acquires EdgeCore Digital Infrastructure, a hyperscale data center platform in the US
EQS-News: KROMI Logistik AG postpones 2022 Annual General Meeting
EQS-News: KROMI Logistik AG postpones 2022 Annual General Meeting
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: HomeServe plc
Form 8.3 - The Vanguard Group, Inc.: HomeServe plc
Form 8.3 - The Vanguard Group, Inc.: Euromoney Institutional Investor plc
Form 8.3 - The Vanguard Group, Inc.: Euromoney Institutional Investor plc
Chelverton UK Dividend Trust plc: Net Asset Value(s)
Chelverton UK Dividend Trust plc: Net Asset Value(s)
Rights and Issues Investment Trust PLC: Net Asset Value(s)
Rights and Issues Investment Trust PLC: Net Asset Value(s)
EQS-News: CureVac Presents Preliminary Data from Phase 1 Study Expansion of Oncology Candidate CV8102
EQS-News: CureVac Presents Preliminary Data from Phase 1 Study Expansion of Oncology Candidate CV8102